Navigation Links
Zonisamide in Medical News

Ranbaxy Ties Up With US Co For Mktg Zonisamide Capsules

Pharma major Ranbaxy Laboratories Ltd has entered into a strategic partnership with US-based Invagen Pharmaceuticals Inc for marketing Zonisamide Capsules // , which are used for the treatment of epilepsy, in the US market. Under the agreement products would be developed and submitted for appr...

FDA Adds Suicide Warning to Epilepsy Drugs

...); methosuximide (Celontin); oxcarbazepine (Trileptal); pregabalin (Lyrica); primidone (Mysoline); tiagabine (Gabitril); trimethadione (Tridione), and zonisamide (Zonegran). Some of these drugs are also available as generics. According to the FDA, antiepileptic drugs are used to treat epilepsy, bipolar disor...

FDA Advisers Don't Back 'Black Box' Warning for Epilepsy Drugs

...d as Lyrica), Tiagabine (marketed as Gabitril), Topiramate (marketed as Topamax), Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) and zonisamide (marketed as Zonegran). Some of these drugs are also available as generics. According to the FDA, antiepileptic drugs are used to treat epilepsy, b...

FDA Advisers Don't Back Epilepsy Drug Warnings

...d as Lyrica), Tiagabine (marketed as Gabitril), Topiramate (marketed as Topamax), Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) and zonisamide (marketed as Zonegran). Some of these drugs are also available as generics. According to the FDA, antiepileptic drugs are used to treat epilepsy, b...

Epilepsy Drugs Can Cause Suicidal Tendencies, FDA Panel Finds

...d as Lyrica), Tiagabine (marketed as Gabitril), Topiramate (marketed as Topamax), Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) and zonisamide (marketed as Zonegran). Some of these drugs are also available as generics. According to the FDA, antiepileptic drugs are used to treat epilepsy, b...

FDA Warns Epilepsy Drugs May Raise Suicide Risk

...d as Lyrica), Tiagabine (marketed as Gabitril), Topiramate (marketed as Topamax), Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) and zonisamide (marketed as Zonegran). Some of these drugs are also available as generics. According to the FDA, antiepileptic drugs are used to treat epilepsy, b...

Pipeline for New Obesity Therapies is Focus of New Report

...s), LH-21 (Instituto de Quimica Medica), Qnexa (phentermine / topiramate; Vivus), Contrave (bupropion / naltrexone; Orexigen), Empatic (bupropion SR + zonisamide SR; Orexigen), Meridia (sibutramine; Abbott), lorcaserin (APD356; Arena), Byetta (exenatide; Amylin/Lilly), exenatide LAR (Lilly/Amylin/Alkermes), exe...
Zonisamide in Medical Technology

Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)

...ic(TM) Empatic is a fixed dose combination of bupropion SR with our proprietary sustained release formulation of zonisamide. Research indicates that zonisamide inhibits AgRP, a system associated with increasing appetite while bupropion increases metabolism. Based on the strength of these results and the uniqu...

Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule

...o exceed $100 billion annually. Empatic combines zonisamide and bupropion, two existing drugs that have been i... proprietary sustained release (SR) formulation of zonisamide that has demonstrated a better tolerability profil.... The efficacy of Empatic will be compared against zonisamide monotherapy, bupropion monotherapy and placebo. Tr...

OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation

... Orexigen(TM) is evaluating zonisamide SR as a novel component in EMPATIC(TM) Phase IIb o...of zonisamide. In the study, the SR formulation of zonisamide achieved a significant reduction in the incidence ... to an immediate release (IR), legacy formulation. zonisamide SR is a key component in the Company's obesity pro...
Zonisamide in Biological Technology

Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union

...Bial towards bringing to patients such a promising new treatment for epilepsy. Zebinix(R) joins our existing family of anti-epileptics, which includes zonisamide and rufinamide and a new molecule currently entering phase three clinical development studies. When launched, Zebinix(R) will help us to fulfil our Co...

Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results

... proprietary sustained release (SR) formulation of zonisamide plus olanzapine. The Phase 2a clinical trial, OZ-1.... 7,425,571 providing broad coverage of the use of zonisamide either alone or in combination with other drugs fo...ued U.S. Patent No. 7,429,580 which broadly covers zonisamide in combination with various marketed atypical anti...

Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain

... - Two Milestones Reached in zonisamide Patent Portfolio - SAN DIEGO, Oct. 2 /PRNewswire...03, a proprietary sustained release formulation of zonisamide plus olanzapine. The Phase 2a clinical trial, OZ-1.... 7,425,571 providing broad coverage of the use of zonisamide either alone or in combination with other drugs fo...

Orexigen Therapeutics Announces Multiple Data Presentations at The Obesity Society Annual Scientific Meeting

...m Weight Loss from a Dose Optimization Study with zonisamide SR and Bupropion SR" Time: 11:00-11:15 a.m. MT ... Improvements from a Dose Optimization Study with zonisamide SR and Bupropion SR" Time: 12:45-2:45 p.m. MT P...ng of Response from a Dose Optimization Study with zonisamide SR and Bupropion SR" Time: 12:45-2:45 p.m. MT ...

OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003

...broad coverage for a pharmaceutical composition of zonisamide in combination with a series of marketed atypical ...ed blood glucose associated with olanzapine alone. zonisamide appears to reverse the olanzapine effects on appet...l trials. If issued, this patent will also cover zonisamide in combination with other atypical antipsychotics,...
Other Tags
(Date:5/30/2015)... 30, 2015 AVT, the world leader ... is joining forces with leading proofing solutions provider Global ... worldwide printing market. , Under the agreement, ... engine for its offline inspection solutions, which are customized ... and its varying production workflow setups and printing applications. ...
(Date:5/30/2015)... Thousands of aesthetic industry professionals converged in ... the American Society for Aesthetic Plastic Surgery (ASAPS). ... the parent company of one of the fastest expanding ... growth, the one-of-a-kind device just sold its 2 millionth ... in the news for gaining the FDA’s stamp of ...
(Date:5/30/2015)... One of the pervasive problems plaguing ... options available. Often, the ruralness of a location can ... rural areas feeling the crunch of a strained healthcare ... of paying high premiums and copays, Online USA ... physicians via the power of the internet. , ...
(Date:5/30/2015)... May 30, 2015 ProIntro Magnify contains 30 ... and animations. Instantly add an elegant opening title to any ... a range of clean design layouts. ProIntro Magnify is created ... is extremely easy to use. Simply drag a preset into ... on-screen-controls and parameters in the Inspector window then watch as ...
(Date:5/30/2015)... Minnesota (PRWEB) May 30, 2015 ... acquired the Disability Income Associate (DIA) designation to ... The DIA designation is designed for insurance advisors, ... to further their knowledge and expertise associated with ... Earning the DIA designation is only the latest ...
Breaking Medicine News(10 mins):Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 2Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 3Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 2Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 3Health News:Announcing the release of ProIntro Magnify from Pixel Film Studios. 2Health News:Secura Consultants Expands Disability Insurance Expertise 2
(Date:5/10/2015)... Fingerprint Cards (FPC) has received an ... the distributor World Peace Industrial Group (WPI), part of WPG ... Asia . Deliveries are planned to take place during ... manufacturers in China . The order value ... of + 1 000 MSEK for 2015.   Jörgen ...
(Date:5/6/2015)... TEL AVIV, Israel , May 6, 2015 /PRNewswire/ ... the world,s most established helmet producer, announced today that ... LifeBEAM Smart Helmet, the world,s first bio-sensing cycling helmet ... will be released in two new colors in order ... demand for the product. In addition, LifeBEAM and Lazer ...
(Date:4/27/2015)... 27, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... customers the first week of May, 2015 and will ... May. Gino Pereira , Chief ... the company as Wocket® enters the consumer market. We ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
Other Contents